VS-4718 Uses, Dosage, Side Effects and more
VS-4718 is under investigation in clinical trial NCT02215629 (Dose Escalation Study in Acute Myeloid or B-Cell Acute Lymphoblastic Leukemia).
| Attribute | Details |
|---|---|
| Trade Name | VS-4718 |
| Generic | VS-4718 |
| Type | |
| Formula | C25H26F3N5O3 |
| Weight | Average: 501.51 Monoisotopic: 501.198774206 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Innovators Monograph
Search Medicines
